Prostatic hyperplasia
Conditions
Interventions
Experimental group:The unilateral local anesthetic was 0.3% ropivacaine 8.75ml+dexamethasone 1ml (5mg)+dexmedetomidine 0.25ml (25ug), and then the operation was performed after a single spinal anesthe
Control group:The unilateral local anesthetic was 0.3% ropivacaine 8.75ml+dexamethasone 1ml (5mg)+0.9% normal saline 0.25ml, and then the operation was performed after a single spinal anesthesia.
Sponsors
Urology, The Third Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-80 years old, ASA1-2 level 2. Confirmed as BPH by B-ultrasound, urodynamics, and serum prostate specific antigen 3. Normal coagulation before surgery, no contraindications for spinal anesthesia and nerve block 4. Choice TURP 5. No Chronic pain 6. No Cognitive Impairments
Exclusion criteria
Exclusion criteria: 1. Prostatic cancer 2. Neurogenic bladder 3. Bladder neck sclerosis or other urethral diseases 4. Refusing spinal anesthesia and nerve block
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective time of pudendal nerve block; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain score;Score of catheter-related bladder discomfort;Incidence of bladder spasm;Total score of bladder spasm subsymptoms; | — |
Countries
China
Contacts
Public ContactLi WeiBing Deng Yinan
The Third Affiliated Hospital of Chongqing Medical University
Outcome results
None listed